UB Paderborn / Katalog / Suche / in CDI

1 – 10 von 10

Sortiert nach

A web server for comparative analysis of single-cell RNA-seq data

Nature communications, 2018-11, Vol.9 (1), p.4768-11, Article 4768

2018

Link zum Volltext

Verfügbarkeit prüfen

Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) From Dolutegravir (DTG)+F/TAF or DTG+F/Tenofovir Disoproxil Fumarate (TDF) in the Presence of Pre-existing NRTI Resistance

Journal of acquired immune deficiency syndromes (1999), 2020-11, Vol.85 (3), p.363

2020

Link zum Volltext

Verfügbarkeit prüfen

Sofosbuvir susceptibility of genotype 1 to 6 HCV from DAA-naïve subjects

Antiviral research, 2019-10, Vol.170, p.104574-104574, Article 104574

2019

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of Broadly Neutralizing Antibody Sensitivity by Genotyping and Phenotyping for Qualifying Participants to HIV Clinical Trials

Journal of acquired immune deficiency syndromes (1999), 2021-09, Vol.88 (1), p.61

2021

Link zum Volltext

Verfügbarkeit prüfen

Genetic conservation of SARS-CoV-2 RNA replication complex in globally circulating isolates and recently emerged variants from humans and minks suggests minimal pre-existing resistance to remdesivir

Antiviral research, 2021-04, Vol.188, p.105033-105033, Article 105033

2021

Link zum Volltext

Verfügbarkeit prüfen

HIV-1 envelope diversity and sensitivity to broadly neutralizing antibodies across stages of acute HIV-1 infection

AIDS (London), 2024-03, Vol.38 (4), p.607

2024

Link zum Volltext

Verfügbarkeit prüfen

629. High Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in African American Adults with HIV Including Those with Preexisting Resistance, Viral Blips, and Suboptimal Adherence

Open forum infectious diseases, 2021-12, Vol.8 (Supplement_1), p.S418-S418

2021

Link zum Volltext

Verfügbarkeit prüfen

109. Preexisting Resistance and Week 48 Virologic Outcomes After Switching to B/F/TAF in African American Adults with HIV

Open forum infectious diseases, 2020-12, Vol.7 (Supplement_1), p.S183-S184

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 10 von 10

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(10)
Mit Volltextzugriff
(7)

Publikationsform

Artikel
(10)

Sprache

Englisch
(10)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(7)
Humans
(6)
Life Sciences & Biomedicine
(6)
Virology
(5)
Drug Resistance
(3)
Drug Resistance, Viral
(3)
Hiv
(3)
Hiv Infections - Drug Therapy
(3)
Hiv-1 - Genetics
(3)
Immunology
(3)
Infectious Diseases
(3)
Resistance
(3)
Adenosine Monophosphate - Analogs & Derivatives
(2)
Adenosine Monophosphate - Pharmacology
(2)
Alanine - Analogs & Derivatives
(2)
Alanine - Pharmacology
(2)
Amino Acids
(2)
Animals
(2)
Broadly Neutralizing Antibodies
(2)
Clinical Trials
(2)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Aids
(2)
Antiviral Research
(2)
Journal Of Acquired Immune Deficiency Syndromes
(2)
Open Forum Infectious Diseases
(2)
Jaids-Journal Of Acquired Immune Deficiency Syndromes
(1)
Nature Communications
(1)
Viruses
(1)

2 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A web server for comparative analysis of single-cell RNA-seq data

Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) From Dolutegravir (DTG)+F/TAF or DTG+F/Tenofovir Disoproxil Fumarate (TDF) in the Presence of Pre-existing NRTI Resistance

Sofosbuvir susceptibility of genotype 1 to 6 HCV from DAA-naïve subjects

Evaluation of Broadly Neutralizing Antibody Sensitivity by Genotyping and Phenotyping for Qualifying Participants to HIV Clinical Trials

No Remdesivir Resistance Observed in the Phase 3 Severe and Moderate COVID-19 SIMPLE Trials

Genetic conservation of SARS-CoV-2 RNA replication complex in globally circulating isolates and recently emerged variants from humans and minks suggests minimal pre-existing resistance to remdesivir

HIV-1 envelope diversity and sensitivity to broadly neutralizing antibodies across stages of acute HIV-1 infection

Evaluation of HIV-1 reservoir size and broadly neutralizing antibody susceptibility in acute antiretroviral therapy-treated individuals

629. High Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in African American Adults with HIV Including Those with Preexisting Resistance, Viral Blips, and Suboptimal Adherence

109. Preexisting Resistance and Week 48 Virologic Outcomes After Switching to B/F/TAF in African American Adults with HIV

Suchergebnisse filtern